14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Motivational, reduction and usual care interventions for smokers who are not ready to quit: a randomized controlled trial : Motivational and reduction interventions

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e164">Aims</h5> <p id="P1">To test whether, in comparison to usual care, brief motivational or reduction interventions increase quit attempts (QA) or abstinence among smokers who are not ready to quit. </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e169">Design</h5> <p id="P2">A parallel-group randomized controlled trial of brief motivational ( <i>n</i>=185), reduction ( <i>n</i>=186), or usual care ( <i>n</i>=189) telephone interventions delivered over the course of 4 weeks. Outcomes were assessed at 6- and 12-month follow-ups. No medication was provided. </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e183">Setting</h5> <p id="P3">United States.</p> </div><div class="section"> <a class="named-anchor" id="S4"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e188">Participants</h5> <p id="P4">560 adult smokers of ≥ 10 cigarettes per day who were not ready to quit in the next 30 days. </p> </div><div class="section"> <a class="named-anchor" id="S5"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e193">Measurements</h5> <p id="P5">The primary outcomes were whether participants made a QA that lasted ≥ 24 hours and whether they made a QA of any length between baseline and 6-months. Secondary outcomes included 7-day point-prevalence abstinence at 6- and 12-months. The 12-month follow-up was added after the study began. </p> </div><div class="section"> <a class="named-anchor" id="S6"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e198">Findings</h5> <p id="P6">A-priori defined comparisons were between motivational versus usual care and reduction versus usual care conditions. The probability of making a QA that lasted ≥ 24 hours was not significantly different between the motivational (38%) or the reduction (31%) conditions and the usual care (34%) condition (motivational versus usual care odds ratio (OR)=1.19 95% confidence interval (CI)=0.78 to 1.82; reduction versus usual care OR=0.89 95% CI=0.57 to 1.36). Bayes factors ranged from 0.13 to 0.18. Findings regarding a QA of any length were similar. At 6 months, the motivational condition had marginally more abstinence than usual care (11% versus 5% OR=2.17 95% CI=0.99 to 4.77) but the reduction condition was not significantly different from usual care (8% versus 5% OR=1.57 95% CI=0.69 to 3.59). At 12 months, the motivational condition had significantly more abstinence than usual care (10% versus 4% OR=2.80 95% CI=1.14 to 6.88) and the reduction condition had marginally more abstinence than usual care (9% versus 4% OR=2.45 95% CI=0.98 to 6.09). </p> </div><div class="section"> <a class="named-anchor" id="S7"> <!-- named anchor --> </a> <h5 class="section-title" id="d346626e203">Conclusions</h5> <p id="P7">Among adult smokers who are not ready to quit, both logistic regression and Bayesian analysis indicate that neither motivational nor reduction-based telephone interventions increased the odds of making a quit attempt in comparison to usual care at 6 months. The motivational intervention appeared to increase abstinence at 6 months and did increase abstinence at 12 months. The reduction intervention did not increase abstinence at 6 months but appeared to increase abstinence at 12 months. </p> </div>

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found

          Measuring processes of change: applications to the cessation of smoking.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Decisional balance measure for assessing and predicting smoking status.

            The Decisional Balance Sheet of Incentives has been proposed by Janis and Mann (1977) as a general schema for representing both the cognitive and motivational aspects of human decision making. In this study, a brief 24-item paper and pencil measure was constructed to study the decision-making process in smoking cessation. Two scales were identified and labeled the Pros of Smoking and the Cons of Smoking. These scales were successful in differentiating between five groups representing stages of change in the quitting process. The two scales were also successful when employed as predictors of smoking status at a 6-month follow-up. The Decisional Balance Scale appears to be a powerful construct of potentially wide application in behavior change.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis

              Objective To determine the effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking. Design Systematic review of randomised controlled trials. Data sources Cochrane Library, Medline, Embase, CINAHL, PsychINFO, Science Citation Index, registries of ongoing trials, reference lists, the drug company that sponsored most of the trials, and clinical experts. Review methods Eligible studies were published or unpublished randomised controlled trials that enrolled smokers who declared no intention to quit smoking in the short term, and compared nicotine replacement therapy (with or without motivational support) with placebo, no treatment, other pharmacological therapy, or motivational support, and reported quit rates. Two reviewers independently applied eligibility criteria. One reviewer assessed study quality and extracted data and these processes were checked by a second reviewer. The primary outcome, six months sustained abstinence from smoking beginning during treatment, was assessed by individual patient data analysis. Other outcomes were cessation and reduction at end of follow-up, and adverse events. Data synthesis Seven placebo controlled randomised controlled trials were included (four used nicotine replacement therapy gum, two nicotine replacement therapy inhaler, and one free choice of therapy). They were reduction studies that reported smoking cessation as a secondary outcome. The trials enrolled a total of 2767 smokers, gave nicotine replacement therapy for 6-18 months, and lasted 12-26 months. 6.75% of smokers receiving nicotine replacement therapy attained sustained abstinence for six months, twice the rate of those receiving placebo (relative risk (fixed effects) 2.06, 95% confidence interval 1.34 to 3.15; (random effects) 1.99, 1.01 to 3.91; five trials). The number needed to treat was 29. All other cessation and reduction outcomes were significantly more likely in smokers given nicotine replacement therapy than those given placebo. There were no statistically significant differences in adverse events (death, odds ratio 1.00, 95% confidence interval 0.25 to 4.02; serious adverse events, 1.16, 0.79 to 1.50; and discontinuation because of adverse events, 1.25, 0.64 to 2.51) except nausea, which was more common with nicotine replacement therapy (8.7% v 5.3%; odds ratio 1.69, 95% confidence interval 1.21 to 2.36). Conclusions Available trials indicate that nicotine replacement therapy is an effective intervention in achieving sustained smoking abstinence for smokers who have no intention or are unable to attempt an abrupt quit. Most of the evidence, however, comes from trials with regular behavioural support and monitoring and it is unclear whether using nicotine replacement therapy without regular contact would be as effective.
                Bookmark

                Author and article information

                Journal
                Addiction
                Addiction
                Wiley
                09652140
                January 2017
                January 2017
                October 05 2016
                : 112
                : 1
                : 146-155
                Affiliations
                [1 ]Vermont Center on Behavior and Health; University of Vermont, Burlington; VT USA
                [2 ]Department of Psychiatry; University of Vermont, Burlington; VT USA
                [3 ]Department of Psychological Science; University of Vermont, Burlington; VT USA
                [4 ]Department of Family Medicine; University of Vermont; Burlington VT USA
                [5 ]Department of Biostatistics; University of Vermont; Burlington VT USA
                Article
                10.1111/add.13594
                5152625
                27566993
                19ac555c-1aee-4f4f-ba7f-f05ec0784f9b
                © 2016

                http://doi.wiley.com/10.1002/tdm_license_1

                http://onlinelibrary.wiley.com/termsAndConditions

                History

                Comments

                Comment on this article